M.P. Fillion

5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.

O. Massot, J.C. Rousselle, M.P. Fillion et al. · Molecular Pharmacology · 1996 · 86 citations

Life Sciences, Neuroscience, Pharmacology +17

Decrease of [³H]5‐HT high affinity binding and 5‐HT adenylate cyclase activation after kainic acid lesion in rat brain striatum

G. Fillion, Dominique Beaudoin, J.-C. Rousselle et al. · Journal of Neurochemistry · 1979 · 49 citations

Life Sciences, Neuroscience, Pharmacology +13

Modulation of affinity of postsynaptic serotonin receptors by antidepressant drugs

G. Fillion, M.P. Fillion · Nature · 1981 · 49 citations

Medicine, Neuroscience, Pharmacology +14

Effects of physical training on functional activity of 5-HT 1B receptors in rat central nervous system: role of 5-HT-moduline

Mounir Chennaoui, B. Grimaldi, M.P. Fillion et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2000 · 46 citations

Life Sciences, Neurobiology, Neuroscience +10

5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety

B. Grimaldi, Alexandre Bonnin, M.P. Fillion et al. · Neuroscience · 1999 · 36 citations

Medicine, Neuroscience, Pharmacology +12